394P Preliminary tolerance analysis of adjuvant chemotherapy in older patients after resection of stage III colon adenocarcinoma from PRODIGE 34-FFCD 1402-ADAGE randomized phase III trial

Thomas Aparicio, O. Bouche,P.L. Etienne,Emilie Barbier,L. Mineur, R. Desgrippes, F. Hocine, J.J. Martin, V. Lebrun-Ly, J. Cretin,Jérôme Desramé, Y. Rinaldi,L. Cany,Claire Falandry,Eric Terrebonne, L. Mosser, M. Pauwels,Anthony Turpin,M. Van den Eynde,Sandrine Hiret

ANNALS OF ONCOLOGY（2021）

引用 1|浏览3

暂无评分

摘要

Colon adenocarcinoma occurs mainly in older patients (pts). Oxaliplatin based adjuvant chemotherapy has demonstrated an improvement on disease-free survival (DFS) after a stage III colon cancer resection in young pts. Nevertheless, the benefit of adjuvant chemotherapy is matter of debate in old pts.

查看译文

关键词

adjuvant chemotherapy,colon adenocarcinoma,prodige

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要